MEDS Company Profile and Key Details

TRxADE HEALTH, Inc. (NASDAQ:MEDS) closed at $7.59 USD, gaining $0.33 (4.55%) from the previous close of $7.26. The stock is currently mid-range between its 52-week high and low $3.69 and $44.56. With a market capitalization of about $13.28 million, TRxADE HEALTH, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~2.17). Key stats such as the average daily volume over the past year has been around 61.78 thousand shares, volume is running light vs its 52-week average. Headquartered in Land O'Lakes, FL, TRxADE HEALTH, Inc. operates in the Healthcare sector and the Medical - Pharmaceuticals industry. Led by CEO Surendra K. Ajjarapu, the company employs approximately 8 people and listed since February 06, 2014. TRxADE HEALTH, Inc. operates as a health services IT company in the United States.

MEDS has shown mixed momentum, gaining 3.14% over the past week and -17.03% over the past quarter, though year-to-date performance is up 45.3%. Short-term trend indicators are mixed aligned (SMA20 4.09%, SMA50 -20.21%, SMA200 3.6%). The stock’s 14-day RSI is 49.47 (neutral), while the ATR of 0.78 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -72.66% below its high and over 230.18% above its low.

TRxADE HEALTH, Inc. trades at a P/E ratio of -0.07, slightly below the S&P 500 average, with a price-to-sales ratio of 0.03 and a price-to-book ratio of 0.05 suggesting the stock is closer to book value. The P/FCF stands at -0.0, also above market averages.

TRxADE HEALTH, Inc. last paid a dividend of 9.5 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$9.42. This means the shares are trading below this model’s fair value.

TRxADE HEALTH, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended August 09, 2024, missed forecasts by 593.33%. The prior quarter beat by 4166.67%. Over the last six quarters, Apple has recorded several small beats. These include 500.0% in November 06, 2023.

TRxADE HEALTH, Inc. has 1.75 million shares outstanding. The public float is 734.54 thousand shares, elevated short interest at 1.13% of float. This equals 15.00 thousand shares. The short ratio is 0.28 days. Institutional investors hold 18.07% of the float. Insiders own 61.7%. Patel Prashant holds 1.25 million shares, AJJARAPU SURENDRA K has 222.50 thousand shares and Fell Donald G. has 21.14 thousand shares.

Our AI price prediction model suggests that TRxADE HEALTH, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 3.61%, with price expected at $7.17 by October 29, 2024, within a range of $6.76 to $7.56 3-Month Outlook: Projected fall of -74.13%, reaching $1.79 by December 19, 2024, with a range of $0.86 to $2.61. 1-Year Outlook: Projected loss of -54.05%, with price at $3.18 by September 19, 2025, within a range of $0.17 to $3.04.

TRxADE HEALTH, Inc. (NASDAQ:MEDS) shares are up 45.3% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows TRxADE HEALTH, Inc. trading at a premium to the broader market with a P/E of -0.07. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $1.42, suggesting -79.48% downside. Our AI forecast model points to short-term strength (3.61% over two weeks), a medium-term fall (-74.13% over three months), and a longer-term loss (-54.05% over one year), with expected trading ranges indicating moderate volatility.